1. Home
  2. SANA vs KRP Comparison

SANA vs KRP Comparison

Compare SANA & KRP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANA
  • KRP
  • Stock Information
  • Founded
  • SANA 2018
  • KRP 2013
  • Country
  • SANA United States
  • KRP United States
  • Employees
  • SANA N/A
  • KRP N/A
  • Industry
  • SANA Medicinal Chemicals and Botanical Products
  • KRP Oil & Gas Production
  • Sector
  • SANA Health Care
  • KRP Energy
  • Exchange
  • SANA Nasdaq
  • KRP Nasdaq
  • Market Cap
  • SANA 983.4M
  • KRP 1.1B
  • IPO Year
  • SANA 2021
  • KRP 2017
  • Fundamental
  • Price
  • SANA $2.84
  • KRP $13.94
  • Analyst Decision
  • SANA Strong Buy
  • KRP Hold
  • Analyst Count
  • SANA 5
  • KRP 5
  • Target Price
  • SANA $8.75
  • KRP $17.40
  • AVG Volume (30 Days)
  • SANA 6.2M
  • KRP 462.6K
  • Earning Date
  • SANA 08-11-2025
  • KRP 08-07-2025
  • Dividend Yield
  • SANA N/A
  • KRP 12.37%
  • EPS Growth
  • SANA N/A
  • KRP N/A
  • EPS
  • SANA N/A
  • KRP N/A
  • Revenue
  • SANA N/A
  • KRP $312,566,668.00
  • Revenue This Year
  • SANA N/A
  • KRP $11.24
  • Revenue Next Year
  • SANA N/A
  • KRP $2.96
  • P/E Ratio
  • SANA N/A
  • KRP N/A
  • Revenue Growth
  • SANA N/A
  • KRP N/A
  • 52 Week Low
  • SANA $1.26
  • KRP $10.98
  • 52 Week High
  • SANA $7.30
  • KRP $16.99
  • Technical
  • Relative Strength Index (RSI)
  • SANA 35.84
  • KRP 44.61
  • Support Level
  • SANA $2.98
  • KRP $13.65
  • Resistance Level
  • SANA $3.49
  • KRP $14.14
  • Average True Range (ATR)
  • SANA 0.25
  • KRP 0.24
  • MACD
  • SANA -0.05
  • KRP -0.01
  • Stochastic Oscillator
  • SANA 2.09
  • KRP 43.74

About SANA Sana Biotechnology Inc.

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

About KRP Kimbell Royalty Partners Common Units Representing Limited Partner Interests

Kimbell Royalty Partners LP owns and acquires mineral and royalty interests in oil and natural gas properties throughout the United States. The company's basins and producing regions include areas of interest in the Permian Basin, Mid-Continent, Terryville/Cotton Valley/Haynesville, Appalachian Basin, Eagle Ford, Bakken/Williston Basin, and DJ Basin/Rockies/Niobrara. Its revenues are derived from royalty payments received from operators based on the sale of oil, natural gas and NGL production, as well as the sale of NGLs that are extracted from natural gas during processing.

Share on Social Networks: